1,248 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Coign Capital Advisors LLC

Coign Capital Advisors LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,248 shares of the medical equipment provider's stock, valued at approximately $651,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $82,517,000. Sycomore Asset Management increased its holdings in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after acquiring an additional 525 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last three months. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

ISRG traded down $5.22 during mid-day trading on Wednesday, reaching $483.05. The stock had a trading volume of 760,468 shares, compared to its average volume of 1,597,162. The stock has a market capitalization of $172.05 billion, a P/E ratio of 75.36, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm's fifty day simple moving average is $528.70 and its two-hundred day simple moving average is $532.45.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ISRG shares. Robert W. Baird decreased their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, March 18th. Truist Financial dropped their price target on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a research report on Monday, March 17th. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.